Skip to main content

Table 1 Characteristics of the human study population (n = 41)

From: Aptamer-based search for correlates of plasma and serum water T2: implications for early metabolic dysregulation and metabolic syndrome

Parameter

Mean ± S.D.

Range

Reference Valuesa

Age

36.5 ± 12.5

23–61

n/a

Gender

n/a

19 female, 22 male

n/a

Body-Mass Index (kg/m2)

26.5 ± 5.5

19.1–45.1

< 25 normal weight, 25–30 overweight, > 30 obese

Plasma T2 (ms)

771.5 ± 58.3

631–887

≥ 745.0b

Serum T2 (ms)

817.4 ± 5.2

706–908

≥ 811.8b

Glucose (mg/dL)

90.6 ± 7.7

71–109

< 100 non-diabetic

100–125 (pre-diabetic)

HbA1c (%)

5.5 ± 0.3

4.7–6.1

< 5.7 (non-diabetic)

5.7–6.4 (pre-diabetic)

Insulin C-peptide (ng/mL)

1.8 ± 0.8

0.7–5.1

0.8–3.9 (> 2.85, IRc)

Insulin (μU/mL)

8.7 ± 6.6

2.2–40.1

2.0–19.6 (> 12.2, IRc)

Total serum protein (g/dL)

7.2 ± 0.4

6.3–8.0

6.1–8.1

Serum albumin (g/dL)

4.5 ± 0.3

3.6–5.1

3.6–5.1

Serum globulins (g/dL)

2.7 ± 0.3

1.9–3.3

1.9–3.7

Triglycerides (mg/dL)

123 ± 63.1

50–321

< 150

Total cholesterol (mg/dL)

185.0 ± 45.0

97–291

< 200

HDL-C (mg/dL)

51.7 ± 12.7

31–78

≥ 40 (male); ≥ 50 (female)

LDL-C (mg/dL)

110.1 ± 35.9

50–191

< 130

WBC count (× 103/μL)

6.6 ± 1.7

3.9–11.2

3.8–10.8

Neutrophil count (× 103/μL)

3.6 ± 1.2

1.8–7.2

1.5–7.8

hs-CRP (mg/L)

2.6 ± 2.7

0.1–9.6

< 3.0 (low/average CV risk)

3.0–10.0 (high CV risk)

> 10.0 (infection/illness)

Sodium (mmoles/L)

138.2 ± 2.6

131–143

135–146

Potassium (mmoles/L)

4.1 ± 0.3

3.7–4.8

3.5–5.3

Total CO2, (mmoles/L)

24.2 ± 2.3

18–28

19–30

  1. aReference values from Quest Diagnostics and Atherotech, except where noted
  2. bCutoff for normoglycemic population established in previous study [8]
  3. cInsulin cutoff from McAuley et al. [67]; insulin C-peptide cutoff established by linear regression with insulin